Symbyax antidepressant and heart birth defects

Symbyax is somewhat different than the above antidepressants. Symbyax combines two psychotropic drugs – olanzapine and fluoxetine – better known Zyprexa and the antidepressant or SSRI, Prozac. Symbyax still is considered a SSRI drug.

Women should notify their doctor if they become pregnant or intend to become pregnant during Symbyax therapy.

Symbyax may be associated with birth defects, specifically, congenital heart defects, Persistent Pulmonary Hypertension of the Newborn (PPHN), abdominal defects, and cranial defects.

Women who breast-feed should not do so while taking Symbyax.

Symbyax is in the drug pregnancy category C meaning that in studies with animals, there were fetal problems. As with most drugs there are no well-controlled Symbyax studies for pregnant women because that would be unethical.

Symbyax should be used during pregnancy only if potential benefits justify potential risks to the fetus.

Do You Have a SSRI Birth Defects Case? »

Has your baby suffered serious heart birth defects or other birth defects because you were prescribed and taking Symbyax while pregnant? If your answer is yes – please contact Monheit Law to find how what your legal options are. Filing a claim might be the answer to astounding medical bills.

How can Monheit Law help you and your family?